My answer to you pmrider is I bought more shares today! YM's $500m takeover deal is fantastic news for the Canadian biotechs. Bioasis is one of the most exciting stories in this young bull market and as such it is one of the best buying opportunities for anyone looking to gett on the biotech bull train.
Besides the technology fundamentals, which were discussed at some lenght on this forum and in my posts for anyone needing a reference, this co has the key ingredients one looks for in a rising jr co:
Proven managment team (Rob has sold a tech company in the past). Low share dilution. Managment ownership, and a very active program (4 pharmas at the table and an exciting Herceptin study). The blue sky potential is certainly there as we are talking about multi-Billion dollar markets.